Guía de Práctica Clínica sobre Cuidados Paliativos - Cedepap TV

122. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain.Cochrane Database Syst Rev. 2005;(3):CD005452.123. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. CochraneDatabase Syst Rev. 2004;(2):CD003726.124. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database SystRev. 2006;3:CD006146.125. Wong Mc, Chung JWY, Wong TKS. Effects of treatments for symptoms of painful diabeticneuropathy: systematic review. BMJ. 2007;335(7610):87.126. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicinfor the treatment of chronic pain. BMJ. 2004;328(7446):991.127. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, ortheir combination for neuropathic pain. N Engl J Med. 2005;352(13):1324-34.128. Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain incancer patients. Cochrane Database Syst Rev. 2006;(1):CD004311.129. Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, et al. Breakthroughcancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) andmorphine sulfate immediate release (MSIR). Pain. 2001;91(1-2):123-30.130. Martinez-Zapata MJ, Roque M, onso-Coello P, Catala E. Calcitonin for metastatic bone pain.Cochrane Database Syst Rev. 2006;3:CD003223.131. Wong R, Wiffen PJ. Bisphosphonates for the relief of pain secondary to bone metastases.Cochrane Database Syst Rev. 2002;(2):CD002068.132. Ross JR, Saunders Y, Edmonds PM, Patel S, Broadley KE, Johnston SRD. Systematic reviewof role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ.2003;327(7413):469.133. Yuen KK, Shelley M, Sze WM, Wilt T, Mason MD. Bisphosphonates for advanced prostatecancer. Cochrane Database Syst Rev. 2006;(4):CD006250.134. Pavlakis N, Schmidt R, Stockler M. Bisphosphonates for breast cancer. Cochrane DatabaseSyst Rev. 2005;(3):CD003474.135. Rosen LS, Gordon DH, Dugan W, Jr., Major P, Eisenberg PD, Provencher L, et al. Zoledronicacid is superior to pamidronate for the treatment of bone metastases in breast carcinomapatients with at least one osteolytic lesion. Cancer. 2004;100(1):36-43.136. McQuay HJ, Collins SL, Carroll D, Moore RA. Radiotherapy for the palliation of painfulbone metastases. Cochrane Database Syst Rev. 2000;(2):CD001793.137. Wai MS, Mike S, Ines H, Malcolm M. Palliation of metastatic bone pain: single fraction versusmultifraction radiotherapy - a systematic review of the randomised trials. Cochrane DatabaseSyst Rev. 2004;(2):CD004721.138. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative Radiotherapy Trials for Bone Metastases:A Systematic Review. J Clin Oncol. 2007;25(11):1423-36.139. Roque M, Martinez MJ, Alonso P, Catala E, Garcia JL, Ferrandiz M. Radioisotopes for metastaticbone pain. Cochrane Database Syst Rev. 2003;(4):CD003347.140. Finlay IG, Mason MD, Shelley M. Radioisotopes for the palliation of metastatic bone cancer:a systematic review. The Lancet Oncology. 2005;6(6):392-400.294 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS